Glucagon-like peptide-1 alleviates diabetic kidney disease through activation of autophagy by regulating AMP-activated protein kinase-mammalian target of rapamycin pathway
Authors:
- 1 December 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 319 (6) , E1019-E1030
Abstract
Glucagon-like peptide-1 (GLP-1) is a novel antidiabetic agent used in clinical practice. Recently, it was reported to exert a renoprotective effect in the human kidney-2 cells and kidneys of diabetic rats, which was induced by one type of GLP-1 analog, liraglutide, in the presence of high glucose. However, most of the previous findings mainly focused on its indirect effect in inhibiting the advanced glycation end products. Here, besides glycemic control, we also demonstrated a stimulatory role of liraglutide in promoting autophagy and relieving oxidative stress in Zucker diabetic fatty rats. The renoprotective effect of liraglutide has been demonstrated by significantly decreasing urinary albumin ( P < 0.01) and ameliorating renal pathological changes ( P < 0.001) in vivo. Besides that, proliferation of human epithelial kidney cell line HKC-8 and human embryonic kidney-293 cells has increased after treating with exendin-4, a GLP-1 receptor (GLP-1R) agonist. Moreover, GLP-1 could positively improve the progression of autophagy in vivo and in vitro through regulating the autophagy-related protein light chain 3 and p62 via AMP-activated protein kinase (AMPK)-mammalian target of rapamycin (mTOR) signaling pathway. Simultaneously, it could reverse NF-erythroid 2-related factor 2 (NRF2) translocation into the nuclei and suppress oxidative stress. In terms of mechanism, the renoprotective effect of GLP-1 would be exerted via the GLP-1R-AMPK-mTOR-autophagy-reactive oxygen species signaling axis. The present study not only illustrates the renoprotective effect of GLP-1 in diabetic kidney disease (DKD) rats, but also for the first time elucidates the underlying mechanism that is independent of controlling glucose, which implies that GLP-1 might be a novel therapeutic strategy for the prevention and treatment of DKD.Keywords
Funding Information
- Science and Technology Plan of Guangdong Province (2016A020215097)
- Science and Technology Plan of Guangdong Province (2017A020215045)
- Guangdong Provincial Department of Education High-level University Construction Funding Southern Medical University Clinical Research Startup Program (LC2016YM007)
- Cultivation of Guangdong College Students' Scientifific and Technological Innovation (pdjh2019b0107)
- National Natural Science Foundation of China (81270966)
- National Natural Science Foundation of China (81500679)
- Natural Science Foundation of Guangdong Province (S2012010009494)
- Natural Science Foundation of Guangdong Province (2014A030310036)
- Natural Science Foundation of Guangdong Province (2014A030310472)
- Natural Science Foundation of Guangdong Province (2017A030313519)
- Natural Science Foundation of Guangdong Province (2018A030313609)
This publication has 25 references indexed in Scilit:
- Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular diseaseClinical Science, 2012
- Autophagy: Renovation of Cells and TissuesCell, 2011
- Comparative Effects of the Long‐Acting GLP‐1 Receptor Ligands, Liraglutide and Exendin‐4, on Food Intake and Body Weight Suppression in RatsObesity, 2011
- Detection of Chronic Kidney Disease With Creatinine, Cystatin C, and Urine Albumin-to-Creatinine Ratio and Association With Progression to End-Stage Renal Disease and MortalityJAMA, 2011
- Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic NephropathyCardiovascular Therapeutics, 2010
- Nutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for AutophagyMolecular Biology of the Cell, 2009
- Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient MiceCell, 2007
- Biology of Incretins: GLP-1 and GIPGastroenterology, 2007
- The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction.Proceedings of the National Academy of Sciences, 1995
- Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region.Proceedings of the National Academy of Sciences of the United States of America, 1994